Skip to main content
Premium Trial:

Request an Annual Quote

Hana Moran, Friedman, Billings, Ramsey & Co.


Nuvelo has appointed Hana Moran vice president of regulatory affairs and quality assurance.

Moran comes to Nuvelo from Lipid Sciences, where she was vice president of regulatory affairs and quality assurance. Before that she held senior management positions at BioMedicines and SangStat Medical Corp.

Lynx Therapeutics has hired Friedman, Billings, Ramsey & Co. to be its financial advisor. In April 2002, FBR acted as sole manager for an approximately $22.6 million private financing of common stock and warrants for common stock for the struggling gene-expression shop.

“We’ve engaged FBR to help us consider opportunities that may be presented to us,” said Kevin Corcoran, Lynx’s president and CEO. “We believe that our Massively Parallel Signature Sequencing services and related products are poised for significant growth in the gene expression market.”

Filed under

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.